Transplanting endothelial progenitor cells in the area of myocardial infarction can activate the VEGFR2-PI3K/Akt-eNOS pathway to increase microvessel density, reduce interstitial fibrosis, and improve myocardial infarction [27]. The gene discussed is KDR; the disease is myocardial infarction.